Luca Szalontay

Luca Szalontay

Pediatric Hematology Oncology

111 Michigan Ave NW
Dept Of Hematology Oncology
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.

Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.

Journal: Science translational medicine

Published: November 12, 2025

A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy.

A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy.

Journal: Neuro-oncology practice

Published: September 10, 2025

National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey.

National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey.

Journal: Journal of neuro-oncology

Published: September 03, 2025

Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

Journal: Nature genetics

Published: September 16, 2024

Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations.

Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2024

Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.

Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.

Journal: Journal of translational medicine

Published: March 22, 2023

Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma.

Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma.

Journal: International journal of radiation oncology, biology, physics

Published: October 31, 2022

Leptomeningeal dissemination in pediatric brain tumors.

Leptomeningeal dissemination in pediatric brain tumors.

Journal: Neoplasia (New York, N.Y.)

Published: September 07, 2022

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.

Journal: Neuro-oncology

Published: February 11, 2022

Medulloblastoma: an Old Diagnosis with New Promises.

Medulloblastoma: an Old Diagnosis with New Promises.

Journal: Current oncology reports

Published: July 10, 2020

Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth.

Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth.

Journal: Peptides

Published: November 16, 2016

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.

Journal: Oncotarget

Published: January 27, 2015

Showing 1-12 of 32

Last Updated: 09/26/2026